Skip to content
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM

Our Publications

  • Our Broadcasts
  • Our Publications
  • Our Analyses
news2021-07-01T19:27:51+00:00

Fire and Ice – Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)

While the M&A dollar volume is hot, a look behind the numbers shows that not everything is, or will be

news2021-07-01T19:27:58+00:00

Calm Before The Storm – Young & Partners (ICIS Chemical Business May 19 – 25, 2017 issue)

First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume

news2021-07-01T19:28:49+00:00

Pharma and Biotech Markets – Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017)

Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry

news2021-07-01T19:29:02+00:00

Peter Young – Chemical Heritage Foundation Bolte Award (2017)

Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day

news2021-07-01T19:29:19+00:00

In M&A, Now You See It, Now You Don’t – Young & Partners ICIS Chemical Business Feb 24, 2017 issue)

Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.

news2021-07-01T19:29:24+00:00

Chemical Financing Hits Record Levels – Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)

Young & Partners analyzes the record dollar value of debt and equity financing in chemicals

news2021-07-01T19:29:31+00:00

Pharma and Biotech Markets – Challenges and Opportunities (Pharma Exec January 2017 Issue)

Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management

news2021-07-01T19:29:37+00:00

A Fireside Chat with Dr. Stephen Miller (Pharmaceutical Executive Magazine Nov 30, 2016)

Peter Young interviews Dr. Stephen Miller of Express Scripts about his career and industry thoughts

news2021-07-01T19:29:44+00:00

Chemical Week – M&A Moderates Despite Announced Mega Deals (November 28, 2016)

Editor-in-Chief interviews Young & Partners about M&A market slowdown and shift to Asia

news2021-07-01T19:29:51+00:00

Capital Markets Shift Amid Volatility (ICIS Chemical Business November 21, 2016 issue)

Young & Partners dissects the volatile debt and equity markets, including the Western IPO drought

Previous789Next

DISCLAIMER

JOIN OUR MAILING LIST

© YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017 | 212-682-5555

Page load link
Go to Top